The Effect of Omega-3 Fatty Acids in Patients with Rheumatoid Arthritis
Launched by HOPITAL CHARLES NICOLLE · Mar 14, 2025
Trial Information
Current as of April 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
Objective:
The aim of this double-blinded randomized controlled trial (RCT) will be to assess the effect of omega-3 intake versus placebo among patients with RA on the primary outcome of disease activity, and the secondary outcomes of function, fatigue and sleep.
Study design This is a prospective, comparative, randomized study, that will be conducted in a single centre (the Rheumatology Department of Charles Nicolle Hospital) during a period of 10 months (from May 2025 to February 2026).
Patients This double-blinded RCT will include adult patients diagnosed with RA according to the Asso...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients ≥ 18 years
- • Patients diagnosed with RA according to the Association of Rheumatology America (ACR) criteria, attending the Rheumatology Department of Charles Nicolle Hospital.
- Exclusion Criteria:
- • Patients with allergy to fish and seafood
- • Patients treated with anticoagulants and coagulation disorders
- • Patients with severe hypertriglyceridemia associated with pancreatitis
- • Patients with severe hepatic impairment
- • Patients with severe renal impairment
- • Current pregnancy or breastfeeding.
About Hopital Charles Nicolle
The Hospital Charles Nicolle is a leading healthcare institution dedicated to providing exceptional medical care and advancing clinical research. Located in Tunisia, it serves as a pivotal center for patient care, education, and innovation in the medical field. With a commitment to improving health outcomes, the hospital actively sponsors and conducts clinical trials across various specialties, facilitating the development of new therapies and treatment modalities. Its multidisciplinary team of healthcare professionals collaborates closely with researchers and regulatory bodies to ensure the highest standards of safety and efficacy in clinical research, ultimately aiming to enhance patient care and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tunis, Bab Saadoun, Tunisia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Related Blog Entries
View all
